Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T M Annesley

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Clinical Pharmacology and Therapeutics|November 1, 1992
Erythromycin breath test predicts oral clearance of cyclosporine in kidney transplant recipientsD K Turgeon, D P Normolle, A B Leichtman, et al.
Clinical Pharmacology and Therapeutics|August 1, 1990
The erythromycin breath test as a predictor of cyclosporine blood levelsP B Watkins, T A Hamilton, T M Annesley, et al.
Clinical Chemistry|April 28, 2001
Glucuronidation of prodrug reactive site: isolation and characterization of oxymethylglucuronide metabolite of fosphenytoinT M Annesley, S Kurzyniec, G D Nordblom, et al.
The Journal of Investigative Dermatology|August 1, 1988
Levels of cyclosporin in epidermis of treated psoriasis patients differentially inhibit growth of keratinocytes cultured in serum free versus serum containing mediaG J Fisher, E A Duell, B J Nickoloff, et al.
Transplantation|June 27, 1994
Prediction of interpatient and intrapatient variation in OG 37-325 dosing requirements by the erythromycin breath test. A prospective study in renal transplant recipientsD K Turgeon, A B Leichtman, D S Blake, et al.
Journal of the American College of Cardiology|May 1, 1987
Role of myocardial ischemia during programmed stimulation in survivors of cardiac arrest with coronary artery diseaseF Morady, L A DiCarlo, R B Krol, et al.
Skin Pharmacology : the Official Journal of the Skin Pharmacology Society|January 1, 1988
Topical ciclosporin for psoriasis: in vitro skin penetration and clinical studyR C Hermann, R S Taylor, C N Ellis, et al.
Clinical Endocrinology|November 1, 1982
Serum immunoreactive melatonin in boys with delayed pubertyH N Cohen, I D Hay, T M Annesley, et al.
Archives of Dermatology|June 1, 1992
Intralesional cyclosporine for psoriasis. Relationship of dose, tissue levels, and efficacyM K Burns, C N Ellis, D Eisen, et al.
JAMA|December 12, 1986
Cyclosporine improves psoriasis in a double-blind studyC N Ellis, D C Gorsulowsky, T A Hamilton, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Clinical Pharmacology and Therapeutics|November 1, 1992
Erythromycin breath test predicts oral clearance of cyclosporine in kidney transplant recipientsD K Turgeon, D P Normolle, A B Leichtman, et al.
Clinical Pharmacology and Therapeutics|August 1, 1990
The erythromycin breath test as a predictor of cyclosporine blood levelsP B Watkins, T A Hamilton, T M Annesley, et al.
Clinical Chemistry|April 28, 2001
Glucuronidation of prodrug reactive site: isolation and characterization of oxymethylglucuronide metabolite of fosphenytoinT M Annesley, S Kurzyniec, G D Nordblom, et al.
The Journal of Investigative Dermatology|August 1, 1988
Levels of cyclosporin in epidermis of treated psoriasis patients differentially inhibit growth of keratinocytes cultured in serum free versus serum containing mediaG J Fisher, E A Duell, B J Nickoloff, et al.
Transplantation|June 27, 1994
Prediction of interpatient and intrapatient variation in OG 37-325 dosing requirements by the erythromycin breath test. A prospective study in renal transplant recipientsD K Turgeon, A B Leichtman, D S Blake, et al.
Journal of the American College of Cardiology|May 1, 1987
Role of myocardial ischemia during programmed stimulation in survivors of cardiac arrest with coronary artery diseaseF Morady, L A DiCarlo, R B Krol, et al.
Skin Pharmacology : the Official Journal of the Skin Pharmacology Society|January 1, 1988
Topical ciclosporin for psoriasis: in vitro skin penetration and clinical studyR C Hermann, R S Taylor, C N Ellis, et al.
Clinical Endocrinology|November 1, 1982
Serum immunoreactive melatonin in boys with delayed pubertyH N Cohen, I D Hay, T M Annesley, et al.
Archives of Dermatology|June 1, 1992
Intralesional cyclosporine for psoriasis. Relationship of dose, tissue levels, and efficacyM K Burns, C N Ellis, D Eisen, et al.
JAMA|December 12, 1986
Cyclosporine improves psoriasis in a double-blind studyC N Ellis, D C Gorsulowsky, T A Hamilton, et al.
Pageof 4